The FDA has granted fast track status to EG-501, an experimental drug to ease lupus brain fog and cognitive issues in people ...

When living with lupus, connecting with others can be challenging, says columnist Candace Semien. Letter writing and pen pals can help.

There is a space that too many people with lupus are forced to live in, between being considered “disabled” and being expected to function as though nothing were wrong. I know that space. Many of you ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Seattle Children’s has been cleared by the U.S. Food and Drug ...

Marisa Zeppieri is a journalist, author of two books, and former Mrs. New York 2015. Her verticals include health, nutrition, food, recipe creation, and food photography. She is also the founder of ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google JW Therapeutics has received approval from Chinese authorities to ...

Telitacicept, a B-cell-targeting therapy developed by RemeGen, outperformed a placebo at reducing the severity of systemic lupus erythematosus (SLE) in a Phase 3 clinical trial in China, the company ...

Lupus News Today is a digital platform intended to provide the lupus community with the most recent news and information, as well as first-hand community perspectives from our patient and caregiver ...

Severe flare-ups of systemic lupus erythematosus (SLE) among patients were associated with a markedly higher risk of stroke, according to the results of a population-based study in Taiwan that ...

Three new Phase 3 clinical trials testing the experimental therapy ianalumab in people with systemic lupus erythematosus (SLE) and lupus nephritis are now recruiting patients. All three trials are ...

This May, organizations will mark Lupus Awareness Month with initiatives and are calling on the lupus community to take action to spread the word. Observed each year, the campaign also includes Lupus ...

The U.S. Food and Drug Administration (FDA) has cleared Century Therapeutics to start a Phase 1 clinical trial that will test its off-the-shelf cell therapy CNTY-101 in people with systemic lupus ...